Journal of Pain Management and Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Opinion Article - Journal of Pain Management and Therapy (2024) Volume 8, Issue 5

The role of analgesics in managing severe pain: Opioid safer approach to pain management

Gary Bennett *

Department of Pharmacology and Neuroscience, University of Michigan, United States

*Corresponding Author:
Gary Bennett
Department of Pharmacology and Neuroscience, University of Michigan, United States
E-mail: bennet@miu.edu

Received: 30-Aug-2024, Manuscript No. AAPMT-24-155526; Editor assigned: 02-Sep-2024, PreQC No AAPMT-24-155526; Reviewed:16-Sep-2024, QC No. AAPMT-24-155526; Revised:23-Sep-2024, Manuscript No. AAPMT-24-155526(R); Published:30-Sep-2024, DOI:10.35841/ aapmt -8.5.226

Citation: Bennett G. The role of analgesics in managing severe pain: Opioid safer approach to pain management. J Pain Manage Ther. 2024;8(5):226.

Visit for more related articles at Journal of Pain Management and Therapy

Introduction

Pain, especially severe pain, is one of the most distressing experiences a person can endure. It can have profound effects on a person’s physical health, emotional well-being, and overall quality of life. For many years, opioids have been the cornerstone of pain management for severe pain conditions, such as those caused by surgery, cancer, or chronic ailments. However, the widespread use of opioids has led to significant concerns about addiction, overdose, and other adverse effects. As a result, the medical community is increasingly exploring opioid alternatives—safer, more sustainable methods to manage severe pain. This article explores the role of analgesics in managing severe pain and delves into the emerging opioid alternatives that provide effective pain relief while reducing the risks associated with opioid use [1].

Severe pain can arise from various sources, including acute injuries, surgery, cancer, or chronic conditions such as arthritis and neuropathy. In such cases, pain relief is not just about comfort but is essential for maintaining physical function, mental health, and overall quality of life. The goal of pain management is not only to reduce the pain but also to enable patients to resume their daily activities and prevent the emotional toll that untreated or poorly managed pain can have [2].

Traditionally, opioids have been prescribed to manage severe pain due to their powerful ability to block pain signals in the brain and spinal cord. Opioids, such as morphine, oxycodone, and fentanyl, work by binding to opioid receptors in the brain, providing significant pain relief. While effective, opioids come with a range of serious risks, including addiction, tolerance (where increasingly larger doses are required to achieve the same effect), and overdose. These risks have led to an opioid crisis, with millions of people becoming addicted to prescription opioids or turning to illicit opioids, like heroin, to satisfy their addiction. In light of these risks, healthcare providers have been focusing on alternative analgesic treatments to provide effective pain relief without the dangers of opioids [3].

Analgesics, also known as pain relievers, are medications specifically designed to alleviate pain without causing a loss of consciousness. There are different classes of analgesics, each with its mechanism of action. The most commonly used analgesics are non-opioid medications, which are often preferred for mild to moderate pain [4].

Opioids are typically used in cases of acute, severe pain or when other treatments have failed. In cancer treatment, for example, opioids are used to manage pain caused by tumors pressing on surrounding tissues. They are also frequently prescribed following surgeries, especially for procedures involving significant tissue damage, such as joint replacement or spinal surgery. Despite their effectiveness, the widespread prescription of opioids for conditions like back pain, headaches, and osteoarthritis has contributed to their abuse, leading to a growing need for safer alternatives [5].

While opioids are highly effective in providing relief for severe pain, their use comes with significant risks. Over time, individuals who take opioids may develop tolerance, meaning that higher doses are needed to achieve the same level of pain relief. This can lead to an escalating cycle of increasing doses, which in turn increases the risk of addiction. Opioid dependence can alter brain chemistry, making it difficult for individuals to function without the drug, even if they no longer require the same level of pain management [6].

7].

In response to the dangers of opioid use, a growing body of research has focused on finding safer alternatives to manage severe pain. These alternatives aim to provide effective pain relief while minimizing the risk of addiction, overdose, and other adverse effects. While no single treatment can replace opioids in all cases, a variety of opioid alternatives have proven to be effective in managing severe pain in different patient populations [8].

While NSAIDs and acetaminophen are commonly used for mild to moderate pain, there are also stronger non-opioid medications that can help manage more severe pain without the risks associated with opioids. For example, certain anticonvulsants, such as gabapentin and pregabalin, are frequently prescribed for nerve pain caused by conditions like diabetes or shingles. These medications work by stabilizing the nerve’s electrical activity, reducing the transmission of pain signals to the brain [9].

In Similarly, certain antidepressants, particularly tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors (SNRIs), have been shown to be effective in treating chronic pain, especially neuropathic pain. These medications alter the way the brain processes pain signals and can help alleviate pain while also addressing any co-occurring mood disorders like anxiety or depression [10].

Conclusion

The role of analgesics in managing severe pain is evolving, particularly with the growing recognition of the risks associated with opioid use. Opioid alternatives, including non-opioid medications, physical therapy, nerve blocks, neuromodulation, and mind-body approaches, offer a safer and often more sustainable approach to pain management. By incorporating a variety of therapies tailored to the individual’s needs, healthcare providers can help patients manage severe pain without relying on opioids, ultimately improving their quality of life while minimizing the risks of addiction, overdose, and long-term complications. As research continues to uncover new and innovative ways to manage pain, patients have more options than ever before to find effective relief and regain control over their lives

References

  1. Cai H, Tu B, Ma J, et al. Psychological impact and coping strategies of frontline medical staff in Hunan between January and March 2020 during the outbreak of coronavirus disease 2019 (COVID-19) in Hubei, China. Med Sci Monit: Int J Clin Exp.. 2020;26:e924171-1.

    2. Indexed at, Google Scholar, Cross ref

  2. Bao Y, Sun Y, Meng S, et al. 2019-nCoV epidemic: address mental health care to empower society. The lancet. 2020; 395(10224):e37-8.

    3. Indexed at, Google Scholar, Cross ref

  3. Day T, Park A, Madras N, et al. When is quarantine a useful control strategy for emerging infectious diseases?. Am J Epidemiol.2006;163(5):479-85.

    4. Indexed at, Google Scholar, Cross ref

  4. Grassi L, Magnani K. Psychiatric morbidity and burnout in the medical profession: an Italian study of general practitioners and hospital physicians. Psychotherapy and psychosomatics. 2000;69(6):329-34.. Psychother. Psychosom. 69, 329–334.

    5. Indexed at, Google Scholar, Cross ref

  5. Brunton PJ, Donadio MV, Yao ST, et al. 5α-Reduced neurosteroids sex-dependently reverse central prenatal programming of neuroendocrine stress responses in rats. J Neurosci. 2015;35(2):666-77.

    6. Indexed at, Google Scholar, Cross ref

  6. Brunton PJ, McKay AJ, Och?dalski T, et al. Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone. J Neurosci. 2009;29(20):6449-60..

    7. Indexed at, Google Scholar, Cross ref

  7. Cheng HY, Papp JW, Varlamova O, et al. microRNA modulation of circadian-clock period and entrainment. Neuron. 2007;54(5):813-29.

    8. Indexed at, Google Scholar, Cross ref

  8. Douglas WW, Poisner AM. Calcium movement in the neurohypophysis of the rat and its relation to the release of vasopressin. J Physiol. 1964;172(1):19.

    9. Indexed at, Google Scholar, Cross ref

  9. Armstrong WE, Wang L, Li C, et al. Performance, properties and plasticity of identified oxytocin and vasopressin neurones in vitro. J Neuroendocrinol. 2010;22(5):330-42.

    10. Indexed at, Google Scholar, Cross ref

  10. Belle MD. Circadian tick?talking across the neuroendocrine system and suprachiasmatic nuclei circuits: the enigmatic communication between the molecular and electrical membrane clocks. J Neuroendocrinol. 2015;27(7):567-76.
Get the App